Opioid Use Disorder -Global Market Status and Trend Report 2013-2023

Table of Contents

Chapter 1 Overview of Opioid Use Disorder

• 1.1 Definition of Opioid Use Disorder in This Report
• 1.2 Commercial Types of Opioid Use Disorder
  • 1.2.1 Buprenorphine
  • 1.2.2 Methadone
  • 1.2.3 Naltrexone
• 1.3 Downstream Application of Opioid Use Disorder
  • 1.3.1 Moderate Pain Treatment
  • 1.3.2 Severe Pain Treatment
• 1.4 Development History of Opioid Use Disorder
• 1.5 Market Status and Trend of Opioid Use Disorder 2013-2023
  • 1.5.1 Global Opioid Use Disorder Market Status and Trend 2013-2023
  • 1.5.2 Regional Opioid Use Disorder Market Status and Trend 2013-2023

Chapter 2 Global Market Status and Forecast by Regions

• 2.1 Market Development of Opioid Use Disorder 2013-2017
• 2.2 Production Market of Opioid Use Disorder by Regions
  • 2.2.1 Production Volume of Opioid Use Disorder by Regions
  • 2.2.2 Production Value of Opioid Use Disorder by Regions
• 2.3 Demand Market of Opioid Use Disorder by Regions
• 2.4 Production and Demand Status of Opioid Use Disorder by Regions
  • 2.4.1 Production and Demand Status of Opioid Use Disorder by Regions 2013-2017
  • 2.4.2 Import and Export Status of Opioid Use Disorder by Regions 2013-2017

Chapter 3 Global Market Status and Forecast by Types

• 3.1 Production Volume of Opioid Use Disorder by Types
• 3.2 Production Value of Opioid Use Disorder by Types
• 3.3 Market Forecast of Opioid Use Disorder by Types

Chapter 4 Global Market Status and Forecast by Downstream Industry

• 4.1 Demand Volume of Opioid Use Disorder by Downstream Industry
• 4.2 Market Forecast of Opioid Use Disorder by Downstream Industry

Chapter 5 Market Driving Factor Analysis of Opioid Use Disorder

• 5.1 Global Economy Situation and Trend Overview
• 5.2 Opioid Use Disorder Downstream Industry Situation and Trend Overview

Chapter 6 Opioid Use Disorder Market Competition Status by Major Manufacturers

• 6.1 Production Volume of Opioid Use Disorder by Major Manufacturers
• 6.2 Production Value of Opioid Use Disorder by Major Manufacturers
• 6.3 Basic Information of Opioid Use Disorder by Major Manufacturers
  • 6.3.1 Headquarters Location and Established Time of Opioid Use Disorder Major Manufacturer
  • 6.3.2 Employees and Revenue Level of Opioid Use Disorder Major Manufacturer
• 6.4 Market Competition News and Trend
  • 6.4.1 Merger, Consolidation or Acquisition News
  • 6.4.2 Investment or Disinvestment News
  • 6.4.3 New Product Development and Launch

Chapter 7 Opioid Use Disorder Major Manufacturers Introduction and Market Data

• 7.1 Orexo
  • 7.1.1 Company profile
  • 7.1.2 Representative Opioid Use Disorder Product
  • 7.1.3 Opioid Use Disorder Sales, Revenue, Price and Gross Margin of Orexo
• 7.2 Camurus
  • 7.2.1 Company profile
  • 7.2.2 Representative Opioid Use Disorder Product
  • 7.2.3 Opioid Use Disorder Sales, Revenue, Price and Gross Margin of Camurus
• 7.3 Hikma Pharmaceuticals
  • 7.3.1 Company profile
  • 7.3.2 Representative Opioid Use Disorder Product
  • 7.3.3 Opioid Use Disorder Sales, Revenue, Price and Gross Margin of Hikma Pharmaceuticals
• 7.4 Alkermes
  • 7.4.1 Company profile
  • 7.4.2 Representative Opioid Use Disorder Product
  • 7.4.3 Opioid Use Disorder Sales, Revenue, Price and Gross Margin of Alkermes
• 7.5 Indivior
  • 7.5.1 Company profile
  • 7.5.2 Representative Opioid Use Disorder Product
  • 7.5.3 Opioid Use Disorder Sales, Revenue, Price and Gross Margin of Indivior
• 7.6 Titan Pharmaceuticals
  • 7.6.1 Company profile
  • 7.6.2 Representative Opioid Use Disorder Product
  • 7.6.3 Opioid Use Disorder Sales, Revenue, Price and Gross Margin of Titan Pharmaceuticals
• 7.7 MediciNova
  • 7.7.1 Company profile
  • 7.7.2 Representative Opioid Use Disorder Product
  • 7.7.3 Opioid Use Disorder Sales, Revenue, Price and Gross Margin of MediciNova
• 7.8 Teva Pharmaceuticals
  • 7.8.1 Company profile
  • 7.8.2 Representative Opioid Use Disorder Product
  • 7.8.3 Opioid Use Disorder Sales, Revenue, Price and Gross Margin of Teva Pharmaceuticals
• 7.9 Omeros
  • 7.9.1 Company profile
  • 7.9.2 Representative Opioid Use Disorder Product
  • 7.9.3 Opioid Use Disorder Sales, Revenue, Price and Gross Margin of Omeros

Chapter 8 Upstream and Downstream Market Analysis of Opioid Use Disorder

• 8.1 Industry Chain of Opioid Use Disorder
• 8.2 Upstream Market and Representative Companies Analysis
• 8.3 Downstream Market and Representative Companies Analysis

Chapter 9 Cost and Gross Margin Analysis of Opioid Use Disorder

• 9.1 Cost Structure Analysis of Opioid Use Disorder
• 9.2 Raw Materials Cost Analysis of Opioid Use Disorder
• 9.3 Labor Cost Analysis of Opioid Use Disorder
• 9.4 Manufacturing Expenses Analysis of Opioid Use Disorder

Chapter 10 Marketing Status Analysis of Opioid Use Disorder

• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
  • 10.1.3 Marketing Channel Development Trend
• 10.2 Market Positioning
  • 10.2.1 Pricing Strategy
  • 10.2.2 Brand Strategy
  • 10.2.3 Target Client
• 10.3 Distributors/Traders List

Chapter 11 Report Conclusion

Chapter 12 Research Methodology and Reference

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources